Chorea Gravidarum
A rare condition where a pregnant woman develops uncontrollable, jerky movements (chorea), often linked to underlying autoimmune diseases or a history of rheumatic fever.
Emergency Management: Chorea gravidarum itself is rarely a medical emergency, but severe uncontrolled movements requiring heavy sedation must be managed in a high-acuity obstetric setting.
Chorea gravidarum is a rare, involuntary movement disorder characterized by rapid, irregular, non-rhythmic, and purposeless movements (chorea) occurring during pregnancy. It is not a distinct disease entity but rather a clinical syndrome where pregnancy precipitates chorea in susceptible individuals.
Detailed Overview
Historically, the most common cause was a reactivation of Sydenham's chorea (related to acute rheumatic fever). Today, in the developed world, it is more commonly associated with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). The chorea usually presents in the first trimester, may persist throughout pregnancy, and typically resolves post-partum, though recurrence in subsequent pregnancies or with oral contraceptive use is common.
Epidemiology & Demographics
Extremely rare, with an incidence of less than 1 in 100,000 pregnancies in modern times due to the decline of acute rheumatic fever. Median age of onset is early to mid-20s.
Etiological Mechanism
Pregnancy acts as a trigger in a predisposed individual. Underlying causes include Antiphospholipid Syndrome (APS), SLE, history of Sydenham chorea, Huntington's disease, or metabolic disturbances (e.g., thyrotoxicosis, Wilson disease).
Primary Causes
Hormonal changes during pregnancy, specifically high estrogen levels, which are thought to upregulate dopaminergic receptors in the basal ganglia, unmasking a subclinical striatal pathology.
The basal ganglia (specifically the striatum) modulates motor control via a balance of dopaminergic, cholinergic, and GABAergic pathways. In chorea gravidarum, a pre-existing striatal vulnerability (e.g., from prior immune-mediated injury in Sydenham's or APS) is unmasked by the hyperestrogenic state of pregnancy. Estrogen has a modulatory effect on dopaminergic transmission, increasing dopamine receptor sensitivity or density. This leads to relative dopaminergic hyperactivity in the striatum, disinhibiting the thalamocortical motor pathways and resulting in hyperkinetic choreic movements.
Diagnostic Criteria & Guidelines
Diagnosis is clinical: onset of chorea during pregnancy. However, an extensive diagnostic workup is mandatory to identify the underlying etiology.
For mild cases: Rest, reassurance, and avoidance of stress, as medications carry teratogenic risks. Treat the underlying cause (e.g., low molecular weight heparin + low-dose aspirin for APS to prevent obstetrical complications).
Second-Line & Adjunctive Therapy
For severe, disabling chorea threatening maternal or fetal health: Typical antipsychotics like Haloperidol (0.5 - 2 mg PO daily, titrated carefully). Haloperidol acts as a dopamine D2 receptor antagonist. Alternative: Clonazepam (0.5 mg PO BID). Both require careful risk/benefit discussion with maternal-fetal medicine due to potential fetal risks.
Surgical & Procedural Management
Not indicated.
Patient Counseling & Advice
Reassure the patient that the movements typically disappear after delivery. Advise against the future use of estrogen-containing oral contraceptives, as they can precipitate a recurrence.
Follow-Up & Monitoring Schedule
Close obstetrical follow-up with Maternal-Fetal Medicine (MFM) and Neurology. Regular fetal monitoring (ultrasounds, NSTs) especially if APS is the underlying cause.
Preventive Strategies
Avoidance of oral contraceptives in women with a history of chorea gravidarum or Sydenham chorea.
The chorea itself generally resolves within a few months post-partum. The long-term prognosis depends entirely on the underlying etiology (e.g., SLE, APS).